Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne
TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...
European Medical Journal5d
The Liver’s Role in Metabolic Regulation and Disease
Metabolic-dysfunction-associated steatotic liver disease (MASLD) arises from excessive intrahepatic triglyceride accumulation ...
Sagimet Biosciences Inc.: Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne
TVB-3567 is the Company's second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 SAN MATEO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences ...
News Medical on MSN5d
Is red meat good or bad for you? Study explains how amino acids shape the answer
Researchers at Texas Tech University reviewed how red meat proteins and amino acids affect human health, weighing both ...
Frontiers2d
Cannabidiol: Perspectives on Drug-Resistant Epilepsy Management
Cannabidiol (CBD) is increasingly recognized for its role as an antiseizure medication, especially for the management of Drug-Resistant Epilepsy (DRE). This ...
India Today on MSN4d
How to protect yourself from liver disease
The deadly Non-Alcoholic Fatty Liver Disease is reaching epidemic proportions in India, with three out of 10 adults and ...